The effects of patient education in COPD in a 1-year follow-up randomised, controlled trial

Lenfant C. Global initiative for chronic obstructive lung disease. Global strategy for the diagnosis, management and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Workshop report. NIH Publication no. 2701, NHLBI; 2001. Gibson PG, Coughlan J, Wilson AJ, et al., editors. Self-management education and regular practitioner review for adults with asthma. Oxford Update Software: Cochrane Review; 2000. Meijer, 1997, Comparison of guidelines and self-management plans in asthma, Eur. Respir. J., 10, 1163, 10.1183/09031936.97.10051163 Gallefoss, 1999, Quality of life assessment after patient education in a randomized controlled study on asthma and COPD, Am. J. Respir. Crit. Care Med., 159, 812, 10.1164/ajrccm.159.3.9804047 Gallefoss, 1999, How does patient education and self-management among asthmatics and patients with chronic obstructive pulmonary disease affect medication ?, Am. J. Respir. Crit. Care Med., 160, 2000, 10.1164/ajrccm.160.6.9901028 Gallefoss, 2000, Patient satisfaction with health care in asthmatics and patients with COPD before and after patient education, Respir. Med., 94, 1057, 10.1053/rmed.2000.0886 Gallefoss F, Bakke PS. Cost-effectiveness of self-management in asthmatics—a one year randomized controlled trial. Eur Respir J 2001:206–13. Decramer M, Donner CF, Schols AMWJ. Rehabilitation. Eur Respir Mon 1998:215–34. Gallefoss F, Bakke PS. Impact of patient education and self-management on morbidity in asthmatics and patients with chronic obstructive pulmonary disease. Respir Med 2000:279–87. Gallefoss, 2002, Cost-benefit and cost-effectiveness analysis of self-management in patients with COPD—a 1-year follow-up randomised, controlled trial, Respir. Med., 96, 424, 10.1053/rmed.2002.1293 Quanjer PH, Tammeling GJ, Cotes JE, Pedersen OF, Peslin R, Yernault JC. Lung volumes and forced ventilatory flows. Report Working Party Standardization of Lung Function Tests, European Community for Steel and Coal. Official Statement of the European Respiratory Society. Eur Respir J Suppl 1993:5–40. Anonymous. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease. American Thoracic Society. Am J Respir Crit Care Med 1995;152:S77–121. Anthonisen, 1986, Bronchodilator response in chronic obstructive pulmonary disease, Am. Rev. Respir. Dis., 133, 814, 10.1164/arrd.1986.133.1.14 Anonymous. Anatomical Therapeutic Chemical (ATC) classification index including Defined Daily Doses (DDDs) for plain substances. WHO Collaborating Centre for Drug Statistics Methodology; 1994. Van der Palen, 1997, Compliance with inhaled medication and self-treatment guidelines following a self-management programme in adult asthmatics, Eur. Respir. J., 10, 652, 10.1183/09031936.97.10030652 Applied Research and Communications Limited. The Life Quality of Asthma, vol. HS 9532-CP. London, UK: Allen & Hanburys; 1991. Jones, 1992, A self-complete measure of health status for chronic airflow limitation. The St. George’s Respiratory Questionnaire, Am. Rev. Respir. Dis., 145, 1321, 10.1164/ajrccm/145.6.1321 Jones, 1991, The St. George’s Respiratory Questionnaire, Respir. Med., 85, S25, 10.1016/S0954-6111(06)80166-6 Jones, 1995, Issues concerning health-related quality of life in COPD, Chest, 107, 187S, 10.1378/chest.107.5_Supplement.187S The Royal Social and Health Department. Pricelist DRG; 1994. Standard fee schedule for the Norwegian Medical Association including National Health Insurance Reimbursement rates and block grants. The Norwegian Medical Association; 1994. Central Bureau of Statistics. Mean hourly wage rates for industrial workers; 1994. Altman DG. Confidence intervals for the number needed to treat. Br Med J 1998:1309–12. Jansson SA, Ericsson Å, Borg S, et al. The economic consequences for society of chronic obstructive pulmonary disease Eur Respir J 2000;16:13s [abstract 268].